These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30065538)

  • 1. Is LNG-IUS the One-Stop Answer to AUB?
    Nayar J; Nair SS; George NA
    J Obstet Gynaecol India; 2018 Aug; 68(4):253-257. PubMed ID: 30065538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial ablation or resection versus levonorgestrel intra-uterine system for the treatment of women with heavy menstrual bleeding and a normal uterine cavity: a systematic review with meta-analysis.
    Bergeron C; Laberge PY; Boutin A; Thériault MA; Valcourt F; Lemyre M; Maheux-Lacroix S
    Hum Reprod Update; 2020 Feb; 26(2):302-311. PubMed ID: 31990359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby A; Hussain M; Rishworth JR; Rees MC
    Cochrane Database Syst Rev; 2015 Apr; (4):CD002126. PubMed ID: 25924648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel intrauterine system: Current role in management of heavy menstrual bleeding.
    Magon N; Chauhan M; Goel P; Malik S; Kapur K; Kriplani A; Dhaliwal L; Pandit SN
    J Midlife Health; 2013 Jan; 4(1):8-15. PubMed ID: 23833527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestogen-releasing intrauterine systems for heavy menstrual bleeding.
    Bofill Rodriguez M; Lethaby A; Jordan V
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD002126. PubMed ID: 32529637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery versus medical therapy for heavy menstrual bleeding.
    Marjoribanks J; Lethaby A; Farquhar C
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD003855. PubMed ID: 26820670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effectiveness of Levonorgestrel-Releasing Intrauterine System in the Treatment of Heavy Menstrual Bleeding.
    Eralil GJ
    J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):505-12. PubMed ID: 27651654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T; Farrant C; Wise MR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the Levonorgestrel-Releasing Intrauterine System in the Treatment of Abnormal Uterine Bleeding and Dysmenorrhea: A Narrative Review.
    Bianchi P; Guo SW; Habiba M; Benagiano G
    J Clin Med; 2022 Oct; 11(19):. PubMed ID: 36233703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
    Sangkomkamhang US; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the levonorgestrel-releasing intrauterine system, hysterectomy, and endometrial ablation for heavy menstrual bleeding in a decision analysis model.
    Louie M; Spencer J; Wheeler S; Ellis V; Toubia T; Schiff LD; Siedhoff MT; Moulder JK
    Int J Gynaecol Obstet; 2017 Nov; 139(2):121-129. PubMed ID: 28796898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are women satisfied when using levonorgestrel-releasing intrauterine system for treatment of abnormal uterine bleeding?
    Mansukhani N; Unni J; Dua M; Darbari R; Malik S; Verma S; Bathla S
    J Midlife Health; 2013 Jan; 4(1):31-5. PubMed ID: 23833531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonorgestrel-Releasing Intrauterine System (52 mg) for Idiopathic Heavy Menstrual Bleeding: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(18):1-119. PubMed ID: 27990196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Dominick S; Hickey M; Chin J; Su HI
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD007245. PubMed ID: 26649916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen.
    Romero SA; Young K; Hickey M; Su HI
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD007245. PubMed ID: 33348436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Combined Bipolar Radiofrequency Impedance-Controlled Endometrial Ablation with Levonorgestrel Intrauterine System versus Bipolar Radiofrequency Endometrial Ablation Alone in Women with Abnormal Uterine Bleeding.
    Zhao H; Yang B; Feng L; Li H; Shang H; Zhao Z; Dai Y
    J Minim Invasive Gynecol; 2020; 27(3):774-780. PubMed ID: 31201942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
    Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
    Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness and impact on health-related quality of life of hysterectomy vs. levonorgestrel intra-uterine system for abnormal uterine bleeding.
    Cozza G; Pinto A; Giovanale V; Bianchi P; Guarino A; Marziani R; Frega A; Caserta D
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2255-2260. PubMed ID: 28537655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.
    Oderkerk TJ; Beelen P; Geomini PMAJ; Herman MC; Leemans JC; Duijnhoven RG; Bosmans JE; Pannekoek JN; Clark TJ; Mol BWJ; Bongers MY
    BMC Womens Health; 2022 Jun; 22(1):257. PubMed ID: 35761328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.